chr6-170561966-AGCAGCAGCAG-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 8P and 9B. PVS1BP6BA1
The NM_003194.5(TBP):c.231_240del(p.Gln77HisfsTer64) variant causes a frameshift change. The variant allele was found at a frequency of 0.00578 in 1,288,298 control chromosomes in the GnomAD database, including 261 homozygotes. Variant has been reported in ClinVar as Benign (no stars). Synonymous variant affecting the same amino acid position (i.e. Q77Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.032 ( 228 hom., cov: 25)
Exomes 𝑓: 0.0025 ( 33 hom. )
Consequence
TBP
NM_003194.5 frameshift
NM_003194.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.03
Genes affected
TBP (HGNC:11588): (TATA-box binding protein) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes TBP, the TATA-binding protein. A distinctive feature of TBP is a long string of glutamines in the N-terminus. This region of the protein modulates the DNA binding activity of the C terminus, and modulation of DNA binding affects the rate of transcription complex formation and initiation of transcription. The number of CAG repeats encoding the polyglutamine tract is usually 25-42, and expansion of the number of repeats to 45-66 increases the length of the polyglutamine string and is associated with spinocerebellar ataxia 17, a neurodegenerative disorder classified as a polyglutamine disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 6-170561966-AGCAGCAGCAG-A is Benign according to our data. Variant chr6-170561966-AGCAGCAGCAG-A is described in ClinVar as [Benign]. Clinvar id is 1174728.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr6-170561966-AGCAGCAGCAG-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBP | NM_003194.5 | c.231_240del | p.Gln77HisfsTer64 | frameshift_variant | 3/8 | ENST00000392092.7 | NP_003185.1 | |
TBP | NM_001172085.2 | c.171_180del | p.Gln57HisfsTer64 | frameshift_variant | 2/7 | NP_001165556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBP | ENST00000392092.7 | c.231_240del | p.Gln77HisfsTer64 | frameshift_variant | 3/8 | 1 | NM_003194.5 | ENSP00000375942 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0322 AC: 4555AN: 141354Hom.: 227 Cov.: 25
GnomAD3 genomes
AF:
AC:
4555
AN:
141354
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00392 AC: 723AN: 184244Hom.: 1 AF XY: 0.00288 AC XY: 296AN XY: 102778
GnomAD3 exomes
AF:
AC:
723
AN:
184244
Hom.:
AF XY:
AC XY:
296
AN XY:
102778
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00251 AC: 2884AN: 1146844Hom.: 33 AF XY: 0.00235 AC XY: 1347AN XY: 573954
GnomAD4 exome
AF:
AC:
2884
AN:
1146844
Hom.:
AF XY:
AC XY:
1347
AN XY:
573954
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0323 AC: 4567AN: 141454Hom.: 228 Cov.: 25 AF XY: 0.0316 AC XY: 2169AN XY: 68740
GnomAD4 genome
AF:
AC:
4567
AN:
141454
Hom.:
Cov.:
25
AF XY:
AC XY:
2169
AN XY:
68740
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at